Get the Stockscreener App
4.62
1.76%
0.08
Cytek Biosciences Inc stock is traded at $4.62, with a volume of 1.61M.
It is up +1.76% in the last 24 hours and up +21.90% over the past month.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
See More
Previous Close:
$4.54
Open:
$4.5
24h Volume:
1.61M
Relative Volume:
1.78
Market Cap:
$587.77M
Revenue:
$193.01M
Net Income/Loss:
$-12.15M
P/E Ratio:
-51.33
EPS:
-0.09
Net Cash Flow:
$454.00K
1W Performance:
+18.46%
1M Performance:
+21.90%
6M Performance:
+23.86%
1Y Performance:
-36.01%
1-Day Range:
$4.39
$4.65
1-Week Range:
$3.795
$4.9104
52-Week Range:
$2.37
$7.30
Cytek Biosciences Inc Stock (CTKB) Company Profile
Name
Cytek Biosciences Inc
Sector
Industry
Phone
(877) 922-9835
Address
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.62 | 580.51M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
126.36 | 217.27B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.02 | 146.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
356.03 | 135.31B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
92.20 | 115.51B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.39 | 47.84B | 5.88B | 1.34B | 577.90M | 2.3489 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-31-25 | Downgrade | Goldman | Buy → Sell |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
Cytek Biosciences Inc Stock (CTKB) Latest News
What technical models suggest about Cytek Biosciences Inc.’s comeback2025 Investor Takeaways & Stock Portfolio Risk Management - newser.com
Is Cytek Biosciences Inc. stock supported by innovation pipelineEarnings Recap Report & AI Based Buy and Sell Signals - newser.com
Can a trend reversal in Cytek Biosciences Inc. lead to recoveryEarnings Growth Summary & AI Driven Stock Movement Reports - newser.com
Cytek Biosciences Insiders May Regret Not Buying More, Market Cap Hits US$510m - simplywall.st
How Cytek Biosciences Inc. stock reacts to bond yieldsJuly 2025 PostEarnings & Weekly Hot Stock Watchlists - newser.com
Cytek Biosciences Earnings Call: Mixed Sentiment and Growth - TipRanks
Cytek reaffirms $196M–$205M 2025 revenue outlook as recurring businesses accelerate - MSN
Cytek Biosciences Muse Micro cell analyzer wins BioTech award - Traders Union
Cytek Biosciences Beats Revenue Estimates But Swings To A Loss - Finimize
Cytek Biosciences' Muse Micro Cell Analyzer Named Drug Discovery Solution of the Year at 2025 BioTech Breakthrough Awards - Quiver Quantitative
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year - The Manila Times
Cytek (NASDAQ: CTKB) wins 2025 BioTech Breakthrough 'Drug Discovery Solution of the Year' - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) to participate in Nov 19 and Dec 3 fireside chats - Stock Titan
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2025 Earnings Call Transcript - Insider Monkey
Can Cytek Biosciences Inc. (8EQ) stock sustain revenue momentum2025 Technical Overview & Reliable Breakout Forecasts - newser.com
Is Cytek Biosciences Inc. (8EQ) stock overpriced at current multiples2025 Breakouts & Breakdowns & Technical Confirmation Alerts - newser.com
Smart tools for monitoring Cytek Biosciences Inc.’s price actionWeekly Profit Analysis & AI Based Trade Execution Alerts - newser.com
Cytek Biosciences earnings missed by $0.01, revenue topped estimates - Investing.com Canada
Why Cytek Biosciences Inc. stock could be next big winnerWeekly Profit Summary & Real-Time Buy Signal Notifications - newser.com
Cytek Biosciences Reports Modest Revenue Growth in Q3 2025 - TipRanks
Can Cytek Biosciences Inc. stock maintain growth trajectoryJuly 2025 WrapUp & Daily Profit Focused Stock Screening - newser.com
Cytek Biosciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Cytek Biosciences Inc (CTKB) Q3 2025 Earnings Call Highlights: Navigating Growth Amid Regional ... By GuruFocus - Investing.com Canada
Will Cytek Biosciences Inc. (8EQ) stock beat growth indexesEarnings Recap Summary & Free Technical Pattern Based Buy Signals - fcp.pa.gov.br
Cytek (CTKB) Q3 2025 Earnings Call Transcript - AOL.com
Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates - sharewise.com
Earnings call transcript: Cytek Biosciences Q3 2025 sees revenue rise, stock steady - Investing.com
[10-Q] Cytek Biosciences, Inc. Quarterly Earnings Report | CTKB SEC FilingForm 10-Q - Stock Titan
Cytek Biosciences, Inc. SEC 10-Q Report - TradingView
Cytek Biosciences Q3 revenue beats estimates, driven by recurring rev growth - MarketScreener
Cytek Biosciences Reports Third Quarter 2025 Financial Results - The Manila Times
[8-K] Cytek Biosciences, Inc. Reports Material Event | CTKB SEC FilingForm 8-K - Stock Titan
Understanding Cytek Biosciences Inc.’s price movementMarket Growth Summary & High Conviction Buy Zone Alerts - newser.com
How strong dollar benefits Cytek Biosciences Inc. (8EQ) stockLong Setup & Weekly Market Pulse Alerts - newser.com
What To Expect From Cytek Biosciences Inc (CTKB) Q3 2025 Earnings - GuruFocus
Comparing Cytek Biosciences Inc. in custom built stock radarsEarnings Trend Report & Breakout Confirmation Alerts - newser.com
Applying Elliott Wave Theory to Cytek Biosciences Inc.2025 Volatility Report & AI Powered Market Trend Analysis - newser.com
Cytek Biosciences, Inc. (CTKB) Stock Forecasts - Yahoo! Finance Canada
Multi factor analysis applied to Cytek Biosciences Inc.Index Update & Risk Controlled Daily Trade Plans - newser.com
How supply chain issues affect Cytek Biosciences Inc. stockWall Street Watch & Expert Curated Trade Setups - newser.com
Cytek Biosciences Inc Stock (CTKB) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.21%
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):